Literature DB >> 26712589

Pain management in head and neck cancer patients undergoing chemo-radiotherapy: Clinical practical recommendations.

A Mirabile1, M Airoldi2, C Ripamonti3, A Bolner4, B Murphy5, E Russi6, G Numico7, L Licitra8, P Bossi9.   

Abstract

Pain in head and neck cancer represents a major issue, before, during and after the oncological treatments. The most frequent cause of pain is chemo/radiation related oral mucositis, which involves 80% of the patients and worsens their quality of life inhibiting speaking, eating, drinking or swallowing and sometimes reducing the treatment compliance, the maximum dose intensity and thus the potential efficacy of treatment. Nevertheless pain is still often under estimated and undertreated. An Italian multidisciplinary group of head and neck cancer specialists met with the aim of reaching a consensus on pain management in this setting. The Delphi Appropriateness method was used for the consensus. External expert reviewers evaluated the final statements. The paper contains 30 consensus-reached statements about pain management in HNC patients and offers a review of recent literature in these topics.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Chemotherapy; Head and neck cancer; Pain; Radiotherapy

Mesh:

Year:  2015        PMID: 26712589     DOI: 10.1016/j.critrevonc.2015.11.010

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  15 in total

1.  Fentanyl pectin nasal spray for painful mucositis in head and neck cancers during intensity-modulated radiation therapy with or without chemotherapy.

Authors:  R Mazzola; F Ricchetti; A Fiorentino; N Giaj-Levra; S Fersino; U Tebano; S Albanese; S Gori; F Alongi
Journal:  Clin Transl Oncol       Date:  2016-11-16       Impact factor: 3.405

2.  The burden of chronic pain after major head and neck tumor therapy.

Authors:  Abdullah Sulieman Terkawi; Siny Tsang; Anwar S Alshehri; Dhaifallah S Mulafikh; Abdulrahman A Alghulikah; Saleh F AlDhahri
Journal:  Saudi J Anaesth       Date:  2017-05

3.  Analgesic and Opioid Use in Pain Associated with Head-and-Neck Radiation Therapy.

Authors:  Sandeep Muzumder; S Nirmala; H U Avinash; Mg John Sebastian; Prashanth Bhat Kainthaje
Journal:  Indian J Palliat Care       Date:  2018 Apr-Jun

4.  Radioprotective Effects of Dermatan Sulfate in a Preclinical Model of Oral Mucositis-Targeting Inflammation, Hypoxia and Junction Proteins without Stimulating Proliferation.

Authors:  Sylvia Gruber; Marlene Arnold; Nilsu Cini; Victoria Gernedl; Sabine Hetzendorfer; Lisa-Marie Kowald; Peter Kuess; Julia Mayer; Susanne Morava; Stephanie Pfaffinger; Andreas Rohorzka; Wolfgang Dörr
Journal:  Int J Mol Sci       Date:  2018-06-06       Impact factor: 5.923

5.  Characteristics of Chronic Pain among Head and Neck Cancer Patients Treated with Radiation Therapy: A Retrospective Study.

Authors:  Anusha Kallurkar; Shreedhar Kulkarni; Kristin Delfino; Daniel Ferraro; Krishna Rao
Journal:  Pain Res Manag       Date:  2019-05-06       Impact factor: 3.037

Review 6.  Tapentadol in the management of cancer pain: current evidence and future perspectives.

Authors:  Hans G Kress; Flaminia Coluzzi
Journal:  J Pain Res       Date:  2019-05-16       Impact factor: 3.133

7.  Intravenous fluids for pain management in head and neck cancer patients undergoing chemoradiation.

Authors:  Charlotte I Rivers; Austin J Iovoli; Udit Chatterjee; Gregory M Hermann; Anurag K Singh
Journal:  Ann Transl Med       Date:  2021-05

Review 8.  Acute and Chronic Pain from Facial Skin and Oral Mucosa: Unique Neurobiology and Challenging Treatment.

Authors:  Man-Kyo Chung; Sheng Wang; Se-Lim Oh; Yu Shin Kim
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

Review 9.  Head and neck cancer: improving outcomes with a multidisciplinary approach.

Authors:  Cristiana Lo Nigro; Nerina Denaro; Anna Merlotti; Marco Merlano
Journal:  Cancer Manag Res       Date:  2017-08-18       Impact factor: 3.989

Review 10.  Quality Assessment in Supportive Care in Head and Neck Cancer.

Authors:  Pierluigi Bonomo; Alberto Paderno; Davide Mattavelli; Sadamoto Zenda; Stefano Cavalieri; Paolo Bossi
Journal:  Front Oncol       Date:  2019-09-18       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.